Nothing Special   »   [go: up one dir, main page]

ZA937592B - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
ZA937592B
ZA937592B ZA937592A ZA937592A ZA937592B ZA 937592 B ZA937592 B ZA 937592B ZA 937592 A ZA937592 A ZA 937592A ZA 937592 A ZA937592 A ZA 937592A ZA 937592 B ZA937592 B ZA 937592B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
ZA937592A
Inventor
Philip Lea
Mark Coke
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA937592B publication Critical patent/ZA937592B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA937592A 1992-10-15 1993-10-13 Pharmaceutical composition ZA937592B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929221707A GB9221707D0 (en) 1992-10-15 1992-10-15 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ZA937592B true ZA937592B (en) 1994-06-01

Family

ID=10723525

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA937592A ZA937592B (en) 1992-10-15 1993-10-13 Pharmaceutical composition

Country Status (7)

Country Link
EP (1) EP0664709A1 (en)
JP (1) JPH08502281A (en)
CN (1) CN1089839A (en)
AU (1) AU5154393A (en)
GB (1) GB9221707D0 (en)
WO (1) WO1994008594A1 (en)
ZA (1) ZA937592B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549911A (en) * 1994-01-14 1996-08-27 Laboratoires Des Produits Ethiques Ethypharm Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract
JP3468244B2 (en) * 1995-12-22 2003-11-17 ナガセケムテックス株式会社 Anti-Helicobacter pylori agent
EP1170013B1 (en) * 1999-03-17 2007-01-17 MORINAGA & CO. LTD. Drugs, foods, drinks and feeds containing cocoa component
MXPA05008571A (en) * 2005-08-12 2007-02-12 Leopoldo Espinosa Abdala Pharmaceutical formulations in the form of solids, semisolids, in suspension, in solution, in emulsion or in syrup, containing clindamycin and one or more members of the azole family.
TWI489984B (en) * 2006-08-04 2015-07-01 Wyeth Corp Formulations for parenteral delivery of compounds and uses thereof
JP2011178722A (en) * 2010-03-01 2011-09-15 Synmosa Biopharma Corp PHARMACEUTICAL COMPOSITION TO ELIMINATE HELICOBACTER PYLORI (H.pylori) AND METHOD FOR PRODUCING THE SAME

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007325A1 (en) * 1988-12-30 1990-07-12 Edko Trading And Representation Company Limited A pessary containing antibacterial drugs

Also Published As

Publication number Publication date
AU5154393A (en) 1994-05-09
WO1994008594A1 (en) 1994-04-28
GB9221707D0 (en) 1992-12-02
EP0664709A1 (en) 1995-08-02
JPH08502281A (en) 1996-03-12
CN1089839A (en) 1994-07-27

Similar Documents

Publication Publication Date Title
ZA938825B (en) Pharmaceutical compositions
GB9209078D0 (en) Pharmaceutical compositions
GB9319500D0 (en) Pharmaceutical composition
HUT66864A (en) Pharmaceutical compositions
GB2272375B (en) Pharmaceutical composition
EP0587047A3 (en) Gestagenes containing pharmaceutical composition
GB9209874D0 (en) Pharmaceutical compositions
CA2100836A1 (en) Pharmaceutical Composition
GB9221707D0 (en) Pharmaceutical composition
ZA94155B (en) Pharmaceutical composition
ZA935078B (en) Pharmaceutical composition
GB9226377D0 (en) Pharmaceutical compositions
ZA924061B (en) Pharmaceutical composition
ZA935931B (en) Pharmaceutical composition
GB9211276D0 (en) Pharmaceutical compositions
ZA931984B (en) Pharmaceutical composition
GB9215976D0 (en) Pharmaceutical composition
GB9203897D0 (en) Pharmaceutical composition
GB9225170D0 (en) Pharmaceutical composition
GB9225159D0 (en) Pharmaceutical composition
GB9221003D0 (en) Pharmaceutical composition
ZA931863B (en) Pharmaceutical composition
GB9203248D0 (en) Pharmaceutical composition
GB9209520D0 (en) Pharmaceutical composition
GB9216596D0 (en) Pharmaceutical composition